Abstract Background Current international guidelines recommend the use of a daily topical exit-site antimicrobial to prevent peritoneal dialysis (PD)-related infections. Although nonantibiotic-based therapies are appealing because they may limit antimicrobial resistance. no controlled trials have been conducted to compare topical antimicrobial agents with usual exit-site care for the ... https://www.chiggate.com/